Trump admin says drug price negotiations will save Medicare roughly $12 billion
November 26, 2025
Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow
November 24, 2025
Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access to its blockbuster weight-loss drug through partnerships with
November 21, 2025
Novo Nordisk said on Monday it would lower the U.S. price of its injectable Wegovy obesity drug and pledged to go "all in" on its
November 17, 2025
Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ahead of the timeline set out with the Trump
November 17, 2025
Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain challenging for patients without insurance
November 17, 2025
Novo Nordisk further lowers prices for weight loss, diabetes drugs for those who pay cash
November 17, 2025
Newly-elected chairman of Wegovy-maker Novo Nordisk, Lars Rebien Sorensen, said on Friday he plans to enhance the board's
November 14, 2025
Novo Nordisk and Eli Lilly denied weight-loss drug partnership with Mangoceuticals on Thursday, hours after the telehealth provider disclosed it had arrangements with
November 13, 2025
Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday.
November 13, 2025
Novo Nordisk and Eli Lilly do not have a weight-loss drug partnership with telehealth website Mangoceuticals Inc, spokespeople for both companies said, rejecting a press release issued by
November 13, 2025
Novo Nordisk faces a shareholder backlash on Friday as the Danish drugmaker's minority investors prepare a protest vote against
November 13, 2025
Pfizer on Thursday closed its up to $10 billion acquisition of Metsera after winning shareholder approval, gaining a foothold in the fast-growing obesity
November 13, 2025
WeightWatchers' CEO said on Wednesday it planned to offer Novo Nordisk's much-anticipated Wegovy in pill form if it is launched next year in the United States,
November 12, 2025
When Novo Nordisk CEO Mike Doustdar learned in late September that Metsera had accepted a $7.3 billion rival bid from Pfizer, he was not
November 12, 2025
Hong Kong votes in legislative election after deadly fire
Magnitude-7.0 earthquake hits in remote wilderness along Alaska-Canada border
Man wounded in 2nd stabbing attack on North Carolina commuter train since August
Chicago doctor dedicated to changing lives of kids with rare neurological diseases
California officials warn against foraging wild mushrooms after deadly poisoning outbreak
James Harden passes Carmelo Anthony to move into 10th place on the NBA's career scoring list
A dismal performance in the SEC title games puts Alabama's playoff hopes in jeopardy
No. 3 Georgia ends No. 10 Alabama's hold on rivalry, beats Crimson Tide 28-7 to win SEC championship